Page 11234..10..»

Archive for the ‘Stem Cell Negative’ Category

BeyondSpring Initiates Expanded Access Program with Plinabulin for Patients Suffering from CIN in the US – BioSpace

Tuesday, August 11th, 2020

- NCCN Guideline Updates Highlight Need for Maximum CIN Prevention and Resource Allocation for COVID-19 Patients - - First Patient Dosed in the U.S. Avoided Grade 4 Neutropenia in Cycle 2 with Plinabulin and Pegfilgrastim, Despite Experiencing Grade 4 Neutropenia in Cycle 1 with Pegfilgrastim Alone - NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BeyondSpring Inc.(the Company or BeyondSpring) (NASDAQ: BYSI), a global biopharmaceutical company focused on the development of innovative immuno-oncology cancer therapies, today announced that the Company has initiated an Expanded Access Program (EAP) to enable doctors across the U.S.

Read More...

CELLECTAR BIOSCIENCES : Management’s Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) – marketscreener.com

Tuesday, August 11th, 2020

Overview We are a clinical stage biopharmaceutical company focused on the discovery,development and commercialization of drugs for the treatment of cancer.

Read More...

A 360-degree approach to getting the perfect glowy skin this summer – Emirates Woman

Sunday, July 12th, 2020

The glow When it comes to supplements, are we too reliant on these miracle capsules for skin-deep beauty? We look at a 360-degree approach instead

Read More...

HIV patient ‘first in remission’ without transplant – Japan Today

Saturday, July 11th, 2020

A HIV-positive man in remission may be the first patient effectively cured of the illness without needing a bone marrow transplant, researchers said Tuesday in a potential breakthrough.

Read More...

Circulating Tumor Cells (CTC) Market Business Overview, Revenue, Price and Gross Margin, Product Specifications, Forecast 2032 Bulletin Line -…

Saturday, July 11th, 2020

A new intelligence report Circulating Tumor Cells (CTC) Market Was recently added to Circulating Tumor Cells (CTC) Market Research collection of top-line market study reports.

Read More...

Global Circulating Tumor Cells Market Analysis and Forecast 2027- including drivers, constraints, intimidation, challenges, opportunities, and…

Saturday, July 11th, 2020

Global Circulating Tumor Cells Market presents insights into the present and upcoming industry trends, enabling the readers to identify the products and services, hence driving the enlargement and effectiveness.

Read More...

These were the best performing ASX 200 shares last week – Motley Fool Australia

Friday, July 10th, 2020

TheS&P/ASX 200 Index(ASX: XJO) was out of form last week and dropped notably lower.

Read More...

Side effects of a stem cell transplant – Canadian Cancer …

Friday, July 10th, 2020

Side effects can happen with any type of treatment, but everyones experience is different. Some people may have many side effects.

Read More...

Triple-negative Breast Cancer | Details, Diagnosis, and Signs

Friday, July 10th, 2020

Triple-negative breast cancer (TNBC) accounts for about 10-15% of all breast cancers. The term triple-negative breast cancer refers to the fact that the cancer cells dont have estrogen or progesterone receptors and also dont make too much of the protein called HER2

Read More...

Brazilian man in long-term HIV remission without a stem cell transplant – aidsmap

Friday, July 10th, 2020

A man in So Paulo who has no evidence of remaining HIV after more than 15 months off antiretrovirals at least according to tests done so far may represent the first case of a functional cure without the risks of a stem cell transplant, according to a report presented today at the23rd International AIDS Conference (AIDS 2020: Virtual). As part of a clinical trial, the 35-year-old man had two additional antiretrovirals, the integrase inhibitor dolutegravir (Tivicay) and the entry inhibitor maraviroc (Celsentri), added to his standard three-drug regimen

Read More...

Fate Therapeutics Announces FDA Clearance of IND Application for First-ever iPSC-derived CAR T-Cell Therapy | 2020-07-09 | Press Releases – Stockhouse

Friday, July 10th, 2020

FT819 CAR T-cell Product Candidate Derived from Clonal Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC Locus Phase 1 Clinical Study will Evaluate FT819 for Patients with Advanced B-cell Leukemias and Lymphomas SAN DIEGO, July 09, 2020 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for FT819, an off-the-shelf allogeneic chimeric antigen receptor (CAR) T-cell therapy targeting CD19+ malignancies

Read More...

Fate Therapeutics Announces FDA Clearance of IND Application for First-ever iPSC-derived CAR T-Cell Therapy – GlobeNewswire

Friday, July 10th, 2020

FT819 CAR T-cell Product Candidate Derived from Clonal Master iPSC Line with Novel CD19-specific 1XX CAR Integrated into TRAC Locus Phase 1 Clinical Study will Evaluate FT819 for Patients with Advanced B-cell Leukemias and Lymphomas SAN DIEGO, July 09, 2020 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced today that the U.S.

Read More...

Stem Cell Cryopreservation Equipment Market Size, Growth Trends, Top Players, Application Potential and Forecast to 2026| Chart, Worthington…

Monday, June 15th, 2020

Los Angeles, United State: QY Research recently published a research report titled, Global Stem Cell Cryopreservation Equipment Market Research Report 2020 The research report is collated on the basis of historic and forecast data derived by using primary and secondary methodologies by researchers. The global Stem Cell Cryopreservation Equipment market is one of the fastest-growing markets and is expected to witness substantial growth in the forecast years

Read More...

It’s National Blood Donor Week, but nowhere to donate in Cape Breton Regional Municipality – The Telegram

Monday, June 15th, 2020

SYDNEY, N.S. Its National Blood Donor Week in Canada, but some Cape Breton Regional Municipality residents are feeling left out

Read More...

UofL researchers to study health impacts of vaping, nicotine on youth – The Lane Report

Monday, June 15th, 2020

LOUISVILLE, Ky. The American Heart Association is investing nearly $17 million to fund a two-year research initiative, ENACT (End Nicotine Addiction in Children and Teens), led by a national network of scientists focusing on the health impacts of e-cigarettes and other nicotine delivery systems on youth and young adults. As part of this network, researchers at the University of Louisville Christina Lee Brown Envirome Institute will conduct studies to better understand youth vaping

Read More...

EHA25Virtual: Combined Irradiation and Chemotherapy Better Prepares Children for Stem Cell Transplantation than Chemotherapy Alone – P&T Community

Sunday, June 14th, 2020

THE HAGUE, Netherlands, June 12, 2020 /PRNewswire/ -- Treatment of childhood cancer is a success story, particularly for acute lymphoblastic leukemia (ALL). More than 90% of ALL patients below 18 years of age are rescued with contemporary chemotherapy

Read More...

Stem Cell Assay Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2026 – Jewish Life News

Sunday, June 14th, 2020

Stem Cell Assay Market Overview The Stem Cell Assay market report presents a detailed evaluation of the market.

Read More...

Stem Cell Therapy Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2026 – Jewish Life News

Sunday, June 14th, 2020

Stem Cell Therapy Market Overview The Stem Cell Therapy market report presents a detailed evaluation of the market.

Read More...

Stem Cell Alopecia Treatment Market Growth Trends, Key Players, Competitive Strategies and Forecasts to 2026 – Jewish Life News

Sunday, June 14th, 2020

Stem Cell Alopecia Treatment Market Overview The Stem Cell Alopecia Treatment market report presents a detailed evaluation of the market.

Read More...

Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress Pivotal AUTO1 study in adult ALL patients enrolling -…

Sunday, June 14th, 2020

AUTO1 continued favorable safety profile and high level of clinical activity, pivotal Phase 1b/2 AUTO1-AL1 program in adult ALL initiated and enrolling patients - AUTO3 profile potentially supports use in a broader outpatient setting Conference Call and Webcast to be held Friday, June 12, 2020at 7:30 am EDT / 12:30 pm BST LONDON, June 12, 2020 --Autolus Therapeutics plc(Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, today announced new data highlighting progress on its AUTO1 program, the companys CAR T cell therapy being investigated in the ongoing ALLCAR Phase 1 study of relapsed / refractory adult B-Acute Lymphocytic Leukemia (ALL), at the European Hematology Association EHA25 Virtual Congress beginning June 11. AUTO1 in ALL As of the data cut-off date ofMay 13, 2020, 19 patients had received AUTO1.AUTO1 was well tolerated, with no patients experiencing Grade 3 CRS

Read More...

Page 11234..10..»


2020 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick